Trinity Resources, Inc. engages in the exploration and development of natural resource interests. The company is headquartered in Henderson, Nevada. The company went IPO on 2001-07-11. The firm is engaged in research and development targeting treatments of brain diseases. The company is also focused on chemical development of its new drugs dedicated to the symptomatic treatment of Alzheimer’s Disease but can be applied to other neurological diseases due to its platform technology.
How did TRRI's recent EPS compare to expectations?
The most recent EPS for Alzex Neuropharma Inc is $, expectations of $.
How did Alzex Neuropharma Inc TRRI's revenue perform in the last quarter?
Alzex Neuropharma Inc revenue for the last quarter is $
What is the revenue estimate for Alzex Neuropharma Inc?
According to of Wall street analyst, the revenue estimate of Alzex Neuropharma Inc range from $ to $
What's the earning quality score for Alzex Neuropharma Inc?
Alzex Neuropharma Inc has a earning quality score of B+/53.489773. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Alzex Neuropharma Inc report earnings?
Alzex Neuropharma Inc next earnings report is expected in
What are Alzex Neuropharma Inc's expected earnings?
Alzex Neuropharma Inc expected earnings is $, according to wall-street analysts.
Did Alzex Neuropharma Inc beat earnings expectations?
Alzex Neuropharma Inc recent earnings of $ expectations.